Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer

BACKGROUND: Locally advanced pancreatic cancer (LAPC) is a common malignant digestive system tumor that ranks as the fourth leading cause of cancer-related death in the world. The prognosis of LAPC is poor even after standard treatment. Irreversible electroporation (IRE) is a novel ablative strategy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yang-Yang, Leng, Yin, Xing, Yan-Li, Li, Hong-Mei, Chen, Ji-Bing, Niu, Li-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716311/
https://www.ncbi.nlm.nih.gov/pubmed/33344547
http://dx.doi.org/10.12998/wjcc.v8.i22.5564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716311/
https://www.ncbi.nlm.nih.gov/pubmed/33344547
http://dx.doi.org/10.12998/wjcc.v8.i22.5564

Ejemplares similares